A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Keywords: محاکمه دو سو کور; Double-blind trial; Infliximab; Cancer-associated weight loss; Elderly patients; Non-small cell lung cancer